Pharmaceutical equipment refers to the special production equipment for chemical raw materials and pharmaceuticals, Chinese medicine decoction pieces and traditional Chinese patent medicines and simple preparations. We can subdivide it into eight types according to the purpose: API equipment and machinery, preparation machinery, pharmaceutical grinding machinery, decoction piece machinery, pharmaceutical water equipment, pharmaceutical packaging machinery, pharmaceutical testing equipment, and pharmaceutical auxiliary equipment. With the development of the pharmaceutical industry, China's pharmaceutical equipment industry has also maintained rapid growth. Next, let's take a look with me.

What are the types of pharmaceutical machinery and equipment

Pharmaceutical equipment is a mechanical equipment used for the production of drugs, including pulverizers, slicers, fryers, decocting machines, tablet presses, pelletizers, multifunctional extraction tanks, storage tanks, dispensing tanks, vacuum drying boxes, tilting reaction pots, capsule filling machines, bubble packaging machines, particle packaging machines, powder packaging machines, V-type mixing machines, lifting feeding machines, etc. These equipment can be divided into eight types according to their usage: raw material pharmaceutical equipment and machinery, preparation machinery, pharmaceutical crushing machinery, tablet machinery, pharmaceutical water equipment, pharmaceutical packaging machinery, pharmaceutical testing equipment, and pharmaceutical auxiliary equipment.

This image is provided by the registered user "Technology Digital Line", and the copyright statement feedback

What is the development status of pharmaceutical equipment

The pharmaceutical industry is an important component of China's national economy, and China's pharmaceutical industry has maintained rapid growth, especially with the acceleration of medical reform process, the increase in medical insurance investment, and the improvement of national medical and health awareness, the scale continues to expand, and the quality and efficiency of economic operation continue to improve.

With the development of the pharmaceutical industry, China's pharmaceutical equipment industry has also maintained rapid growth. Firstly, in terms of pharmaceutical safety, the "12th Five Year Plan for the Development of the National Pharmaceutical Industry" proposes to fully implement the new version of GMP and strictly implement it, significantly improving the overall level of drug quality management in China. Encourage eligible enterprises to carry out GMP certification from developed countries or WHO, and drive China's drug quality management to align with international standards. In December 2011, the European Union officially issued Directive 2011/62/EU, raising the threshold for drug imports.

The European Union is the largest export market for chemical and pharmaceutical products in China. Although the latest GMP standards implemented in China cover the basic requirements of the European Union, the US FDA, and WHO for GMP, with hardware referring to the EU standards and software referring to the US FDA standards, the level of rigor is unprecedented in Chinese pharmaceutical history. However, among Chinese pharmaceutical export enterprises, only a few large enterprises have GMP recognition from both China and the EU, Therefore, the promulgation of new standards will inevitably accelerate the production transformation and upgrading of export enterprises.

Against the backdrop of the introduction of the new version of the European Union GMP standard, the comprehensive implementation of the new version of GMP in China, and the improvement of environmental requirements for pharmaceuticals, the growth rate of the market capacity of raw material pharmaceutical equipment will be more outstanding in the future. On the one hand, raw material pharmaceuticals account for about 50% of China's Western medicine exports to the European Union market, with a relatively large proportion. On the other hand, raw materials are the modules with the most severe environmental pollution among pharmaceutical companies, so their demand for environmental investment is also greater.